Veeva Systems (NYSE:VEEV) Coverage Initiated by Analysts at UBS Group

Veeva Systems logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • UBS initiated coverage of Veeva Systems with a neutral rating and a $310 price target, implying 17.33% upside from the share price cited in the article.
  • Analyst sentiment overall is more positive: MarketBeat reports a “Moderate Buy” consensus and an average price target of $316.79, with 19 Buy, 8 Hold, and 1 Sell rating.
  • Veeva shares fell 4.7% in Thursday trading to $264.21. In its latest reported quarter, the company beat earnings and revenue estimates, while revenue grew 17.6% year over year.
  • Five stocks we like better than Veeva Systems.

Research analysts at UBS Group began coverage on shares of Veeva Systems (NYSE:VEEV - Get Free Report) in a research note issued on Thursday, Benzinga reports. The firm set a "neutral" rating and a $310.00 price target on the technology company's stock. UBS Group's price objective suggests a potential upside of 17.33% from the stock's current price.

A number of other equities analysts also recently weighed in on VEEV. Evercore boosted their target price on Veeva Systems from $185.00 to $250.00 in a research note on Thursday, October 8th. Guggenheim increased their price target on Veeva Systems from $276.00 to $310.00 and gave the company a "buy" rating in a research report on Thursday, August 27th. Raymond James Financial lifted their price target on Veeva Systems from $225.00 to $330.00 in a report on Thursday, August 27th. Canaccord Genuity Group boosted their price objective on Veeva Systems from $260.00 to $315.00 and gave the stock a "hold" rating in a research report on Monday, November 9th. Finally, Jefferies Financial Group upped their price objective on Veeva Systems from $295.00 to $375.00 and gave the company a "buy" rating in a research note on Friday, November 6th. Nineteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $316.79.

Read Our Latest Report on Veeva Systems

Veeva Systems Stock Down 4.7%

Shares of VEEV stock traded down $12.99 during mid-day trading on Thursday, reaching $264.21. 1,632,604 shares of the stock traded hands, compared to its average volume of 2,229,394. The company has a market cap of $42.78 billion, a price-to-earnings ratio of 43.54, a price-to-earnings-growth ratio of 1.23 and a beta of 0.89. The stock's fifty day simple moving average is $292.83 and its two-hundred day simple moving average is $215.18. Veeva Systems has a 1-year low of $148.05 and a 1-year high of $325.99.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.23 by $0.12. The company had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The firm's revenue was up 17.6% compared to the same quarter last year. During the same period last year, the company earned $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, equities research analysts anticipate that Veeva Systems will post 6.70 EPS for the current fiscal year.

Insider Activity at Veeva Systems

In other Veeva Systems news, EVP Daniel J. Rizzo sold 4,841 shares of the company's stock in a transaction that occurred on Friday, October 2nd. The stock was sold at an average price of $276.51, for a total value of $1,338,584.91. Following the completion of the sale, the executive vice president owned 7,665 shares of the company's stock, valued at $2,119,449.15. This represents a 38.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Jonathan Faddis sold 5,198 shares of the company's stock in a transaction dated Wednesday, October 14th. The shares were sold at an average price of $299.72, for a total transaction of $1,557,944.56. Following the sale, the senior vice president owned 4,130 shares of the company's stock, valued at approximately $1,237,843.60. The trade was a 55.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 20,789 shares of company stock valued at $5,905,609 in the last ninety days. 10.60% of the stock is currently owned by company insiders.

Institutional Trading of Veeva Systems

Several large investors have recently modified their holdings of VEEV. Fi3 FINANCIAL ADVISORS LLC purchased a new stake in shares of Veeva Systems in the 3rd quarter worth approximately $241,000. Innovator Capital Management LLC bought a new position in Veeva Systems during the 3rd quarter valued at approximately $2,370,000. Coastal Bridge Advisors LLC purchased a new position in Veeva Systems during the third quarter valued at $816,000. Zacks Investment Management purchased a new position in Veeva Systems during the third quarter valued at $240,000. Finally, Integrated Wealth Concepts LLC boosted its holdings in Veeva Systems by 22.9% in the third quarter. Integrated Wealth Concepts LLC now owns 4,128 shares of the technology company's stock worth $1,178,000 after acquiring an additional 769 shares in the last quarter. 88.20% of the stock is owned by institutional investors.

About Veeva Systems

(Get Free Report)

Veeva Systems Inc. develops cloud-based software, data and consulting services for the life sciences industry. Its customers include pharmaceutical and biotechnology companies, medical device makers and contract research organizations. The company's products support commercial operations as well as clinical, regulatory, quality and safety activities. Its offerings include Veeva Vault applications for managing documents and business processes, customer relationship management software, and data and analytics services.

See Also

Analyst Recommendations for Veeva Systems (NYSE:VEEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines